Reckitt Benckiser Group (RBGLY) Expected to Announce Earnings on Thursday

by · The Markets Daily

Reckitt Benckiser Group (OTCMKTS:RBGLY – Get Free Report) is expected to announce its results before the market opens on Thursday, March 5th. Analysts expect the company to announce earnings of $0.5110 per share and revenue of $9.8490 billion for the quarter.

Reckitt Benckiser Group Stock Performance

Shares of OTCMKTS:RBGLY traded down $0.19 on Tuesday, hitting $16.27. 41,267 shares of the company’s stock were exchanged, compared to its average volume of 504,240. The company has a current ratio of 0.56, a quick ratio of 0.37 and a debt-to-equity ratio of 1.01. Reckitt Benckiser Group has a 1-year low of $11.99 and a 1-year high of $16.80. The firm’s 50-day moving average is $16.80 and its 200 day moving average is $15.95.

Analyst Ratings Changes

Several brokerages have commented on RBGLY. Barclays upgraded shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research note on Monday, December 1st. Royal Bank Of Canada cut shares of Reckitt Benckiser Group from an “outperform” rating to a “sector perform” rating in a research report on Wednesday, January 14th. Citigroup assumed coverage on shares of Reckitt Benckiser Group in a research note on Wednesday, January 14th. They issued a “buy” rating for the company. Morgan Stanley cut Reckitt Benckiser Group from an “overweight” rating to an “equal weight” rating in a research report on Monday, December 15th. Finally, Jefferies Financial Group reissued a “hold” rating on shares of Reckitt Benckiser Group in a research report on Wednesday, January 7th. Two investment analysts have rated the stock with a Strong Buy rating, one has given a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy”.

Read Our Latest Report on Reckitt Benckiser Group

About Reckitt Benckiser Group

(Get Free Report)

Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.

The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.

Recommended Stories